Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Denali reports net loss of $39M in Q1 2019
May 9, 2019 Off

Denali reports net loss of $39M in Q1 2019

By Dino Mustafić

Denali has reported net loss of $39.0 million in the first quarter 2019, compared with a net loss of $23.7 million same period last year.

May 9, 2019 Off

Takeda sells Xiidra to Novartis for up to $5.3B, TachoSil to Ethicon for $400M

By BusinessWire

Takeda sells Xiidra to Novartis for up to$5.3 billion, TachoSil to Ethicon for approximately $400 million

Bicycle Therapeutics adds two senior figures to clinical team to advance expanding pipeline
May 9, 2019 Off

Bicycle Therapeutics adds two senior figures to clinical team to advance expanding pipeline

By BusinessWire

Bicycle Therapeutics today announced two senior appointments to facilitateits expanding and advancing clinical pipeline.

Promethera doses patients with HepaStem testing drug for Liver Stem Cell Therapy in Late-Stage NASH
May 9, 2019 Off

Promethera doses patients with HepaStem testing drug for Liver Stem Cell Therapy in Late-Stage NASH

By BusinessWire

Promethera doses patients with HepaStem drug testing it in late stage non-alcoholic steatohepatitis

‘A Vision for Lupus’ Report, Published Ahead of World Lupus Day, Highlights an Important Need to Improve Quality of Care for Lupus Patients
May 9, 2019 Off

‘A Vision for Lupus’ Report, Published Ahead of World Lupus Day, Highlights an Important Need to Improve Quality of Care for Lupus Patients

By BusinessWire

Systemic Lupus Erythematosus (SLE), also known as lupus, is a chronic,inflammatory, autoimmune disease affecting 5 million people worldwidewith 70%-90% of these cases appearing in females

May 9, 2019 Off

Twist Bioscience Announces Pricing of $78.8 Million Public Offering of Common Stock

By BusinessWire

SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DNA?src=hash" target="_blank"gt;#DNAlt;/agt;–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality…

May 9, 2019 Off

Cortexyme, Inc. Announces Pricing of Initial Public Offering

By BusinessWire

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to…

May 8, 2019 Off

CORRECTING and REPLACING McKesson Reports Fiscal 2019 Fourth-Quarter and Full-Year Results

By BusinessWire

Fourth-quarter fiscal 2019 revenues of $52.4 billion and full-year fiscal 2019 revenues of $214.3 billion, a full-year increase of 3%.…

May 8, 2019 Off

BELLUS Health Provides Update on Its Chronic Cough Drug Candidate BLU-5937 and Reports Financial and Operating Results for the First Quarter Ended March 31, 2019

By BusinessWire

LAVAL, Quebec–(BUSINESS WIRE)–BELLUS Health Inc. (TSX: BLU) (BELLUS Health or the Company), a clinical-stage biopharmaceutical company developing novel therapeutics for…

May 8, 2019 Off

Virginia Outstanding Contribution to Life Science Inducts Three Award Winners

By BusinessWire

RICHMOND, Va.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/boardroom?src=hash" target="_blank"gt;#boardroomlt;/agt;–Virginia Bio, the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth…

Posts pagination

Previous 1 … 3,210 3,211 3,212 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine